US FDA puts clinical hold on Kezar Life Sciences’ lupus treatment trial

FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland

(Reuters) – The U.S. Food and Drug Administration has placed a clinical hold on Kezar Life Sciences’ trial of experimental drug for lupus, the company said on Friday.

(Reporting by Mariam Sunny in Bengaluru; Editing by Mohammed Safi Shamsi)